Literature DB >> 15477441

Safety of anticoagulation therapy in well-informed older patients.

Nadya Kagansky1, Hilla Knobler, Ephraim Rimon, Zinaida Ozer, Shmuel Levy.   

Abstract

BACKGROUND: In older populations, oral anticoagulation therapy (OAT) is underused by physicians, mainly because of fear of bleeding complications. The aim of this study was to determine the incidence of bleeding complications and associated risk factors in a large heterogeneous group of older patients.
METHODS: Combined retrospective and prospective cohort study conducted in geriatric and internal medicine departments. All patients 80 years or older discharged with the recommendation of OAT were followed up for a mean +/- SD of 28.8 +/- 36.3 months. The rate of bleeding events and the quality of anticoagulation were compared across a wide range of demographic and clinical variables and cognitive and functional status. In addition, we assessed the quality of education given to the patient or caregiver on the use of OAT.
RESULTS: Among 15 387 patients 80 years or older, 323 (2.1%) were discharged with the recommendation of OAT. The rate of major bleedings was 2.4 events per 1000 patient-months. Socioeconomic and cognitive variables and functional impairments were not associated with an increased rate of bleeding. In multivariate analysis, insufficient education on OAT as perceived by the patient or caregiver (odds ratio [OR], 8.83), polypharmacy (OR, 6.14), and international normalized ratio values above the therapeutic range (OR, 1.08) were the only significant predictive factors for bleeding complications.
CONCLUSIONS: The rate of bleeding complications, especially major bleedings, was low in this large group of older patients, many with comorbidities and cognitive and functional impairments. Insufficient OAT education was the major factor that predicted bleeding. Therefore, improving and fostering better methods of OAT education may further reduce bleeding complications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15477441     DOI: 10.1001/archinte.164.18.2044

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  41 in total

1.  Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy.

Authors:  Andrea Rubboli; Cecilia Becattini; Freek Wa Verheugt
Journal:  World J Cardiol       Date:  2011-11-26

Review 2.  [Oral anticoagulation and risk of bleeding in elderly patients - the aspect of polypharmacy].

Authors:  Regina E Roller; Bernhard Iglseder; Peter Dovjak; Monika Lechleitner; Ulrike Sommeregger; Ursula Benvenuti-Falger; Ronald Otto; Birgit Böhmdorfer; Markus Gosch
Journal:  Wien Med Wochenschr       Date:  2010-06

Review 3.  Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Anne Holbrook; Sam Schulman; Daniel M Witt; Per Olav Vandvik; Jason Fish; Michael J Kovacs; Peter J Svensson; David L Veenstra; Mark Crowther; Gordon H Guyatt
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  Provision of warfarin education to hospital inpatients.

Authors:  Christopher Baughman; Lisa Spurling; Arduino A Mangoni
Journal:  Br J Clin Pharmacol       Date:  2008-07-23       Impact factor: 4.335

Review 5.  Concerns about the use of new oral anticoagulants for stroke prevention in elderly patients with atrial fibrillation.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

Review 6.  Antithrombotic therapy for the treatment of atrial fibrillation in the elderly.

Authors:  Margaret C Fang
Journal:  J Interv Card Electrophysiol       Date:  2009-01-16       Impact factor: 1.900

7.  EDUC'AVK: reduction of oral anticoagulant-related adverse events after patient education: a prospective multicenter open randomized study.

Authors:  Gilles Pernod; José Labarère; Jacqueline Yver; Bernadette Satger; Benoit Allenet; Touffek Berremili; Michèle Fontaine; Guy Franco; Jean Luc Bosson
Journal:  J Gen Intern Med       Date:  2008-06-20       Impact factor: 5.128

8.  Correlation of point-of-care International Normalized Ratio to laboratory International Normalized Ratio in hemodialysis patients taking warfarin.

Authors:  Robert W Hoel; Robert C Albright; Lisa K Beyer; Paula J Santrach; Donna L Magtibay; Stephanie L Everson; Robert D McBane
Journal:  Clin J Am Soc Nephrol       Date:  2008-11-05       Impact factor: 8.237

Review 9.  Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient.

Authors:  Michael Makris; Joost J van Veen; Rhona Maclean
Journal:  J Thromb Thrombolysis       Date:  2010-02       Impact factor: 2.300

Review 10.  Use of anticoagulants in elderly patients: practical recommendations.

Authors:  Helia Robert-Ebadi; Grégoire Le Gal; Marc Righini
Journal:  Clin Interv Aging       Date:  2009-05-14       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.